1. Introduction
Oestrogen plays an important role in bird sex differentiation, which is essential for the growth of ovaries and the regulation of the proliferation of the left gonadal cortex [
1]. In addition, 17b-Hydroxysteroid dehydrogenase and aromatase enzymes that are responsible for converting androgens to estradiol-17b are detectable only in the gonads of female embryos [
2]. Oestrogens cause their effects in target cells through oestrogen receptors (ERs) located not only in the ovary and oviduct but also in different tissues including the pituitary gland and hypothalamus [
3]. Many studies have been applied to induce sex reversal from female to male by suppression of oestrogen secretion to obtain the benefits of unisex males. Tamoxifen (TAM), which is one of the aromatase inhibitors, induces a wide range of activity in different species [
4]. TAM has been suggested not to be a pure oestrogenic antagonist, but it has both antiestrogenic and oestrogenic effects, depending on the dose given [
5]. Low doses of TAM advanced ovarian and oviductal development, increased oestrogen and androgen in plasma, and induced early egg laying in hens [
6,
7]. In the contrast, the administration of high doses of TAM caused blockage of oestrogen receptors leading to a progressive decrease in the laying of eggs before their complete cessation [
8]. TAM‘s impact at different ages has been studied, either by ova inoculation to estimate its influence on sex determination as a modulator for oestrogen receptors [
9,
10,
11,
12] or hatch day [
9] or even older ages to assess its impact on hormonal profile and reproductive system [
6,
13,
14]. Additionally, the various administration techniques of Tamoxifen were studied: in-ovo inoculation [
9], per os in gelatine capsules [
15] and intra muscular injection as well as the use of different preparation doses, e.g., 0.5; 1.0; 5.0; 10.0 or even 25 mg/kg body weight. However, the effect of Tamoxifen supplementation on performance of different broiler breeds has not been studied.
Therefore, the present study was conducted to investigate the effect of early oral Tamoxifen administration at different doses on growth performance, carcass characteristics, hormonal profile and histological structure of sex organs of two different broiler breeds up to 42 days of age.
2. Materials and Methods
2.1. Birds and Experimental Design
The present study was conducted at a research center for poultry production, the Faculty of Veterinary Medicine of the Damanhour University. The experimental protocol regarding the care and handling of animals was approved by the Native Experimental Animal Care Committee and approved by the Ethics of the Institutional Committee of Animal Husbandry and Animal Wealth Development Department, Faculty of Veterinary Medicine, Damanhour University, Damanhour, Egypt (DMU/VetMed-2019-/0145). On the same day, one-hundred-and-eighty-day-old chicks from each of the Avian48 and Arbor Acres breeds were sourced from local country hatcheries. Chicks from each breed were wing banded at first day of age; then divided into three groups of 60 chicks; chicks of each group were subdivided into 5 replicates (10 chicks/replicate). The groups were 1. Control group, Tamoxifen; 2. TAM10 group in which chicks obtained TAM on the third, fifth, seventh and ninth day of age by oral administration at level of 10 mg per kg of body weight; and 3. TAM20 group in which chicks got 20 mg TAM per kg of body weight at the same time intervals. TAM (Amriya for Pharmaceutical Industries, Alexandria, Egypt) was used as TAM citrate. Chicks were brooded under gas brooders supplying 33 °C at the first week and reduced by 3 °C per week to 24 °C. For the first week of life, illumination was supplied for 24 h then the lighting time was shortened to 18 h a day. Birds were fed a starter ration of 23% crude protein (CP) during the first three weeks of age then provided with a grower ration of 21% CP until the end of experiment at 42 days; ration and water were offered ad libitum during the experimental period. The experimental diets were formulated according to National Research Council (NRC) [
16] recommendations. The ingredient content and composition of the diets is shown in
Table 1.
2.2. Productive Efficiency
The measured productive performance traits including weekly body weight (g), weekly weight gain, weekly feed consumption (g/bird/week) and weekly feed conversion ratio.
2.3. Reproductive Efficiency
Reproductive efficiency evaluation included measuring of serum concentrations of sex hormones and histological evaluations of the gonads. Blood samples were collected twice at 35 and 42 days from the wing vein of the same birds. Three birds per replicate were used for blood collection, serum was separated for 15 min by centrifugation at 3000 rpm, and preserved in a deep freezer at −20 °C until the time of analysis. The concentrations of serum testosterone and oestrogen were determined by enzyme-linked immunosorbent assay (ELISA) using a commercial ELISA kit (Wuhan Fine Biotech Co., Ltd., China) according to the manufacturer’s instructions.
Left and right gonads were taken from three males and three females of each treatment following the macroscopic examination. Gonads were sliced into smaller pieces, fixed in 4% paraformaldehyde in 0.1M phosphate buffer saline (PBS) (PH 7.4) overnight at −40 °C. After fixation, tissues were processed for histological examination starting with dehydration in ascending grades of ethyl alcohols, cleared with xylene and embedding with melted paraffin wax. Later, 6-µm-thick sections were dewaxed and stained with hematoxylin and eosin stain. Images were captured using a Nikon DM ×1200 digital camera (Tokyo, Japan) at a magnification of ×20 and ×400, and saved in JPEG format.
2.4. Carcass Traits
Carcass traits assessed at 42 days of age after three birds per replicate were selected randomly and deprived of food for 12 h with persistence on water. The selected birds were weighed before slaughtering then reweighed again after evisceration to calculate dressing percentage. Abdominal fat with fat around the gizzard; internal organs (intestine, liver, gizzard and heart), comb and wattle were weighed to the nearest gram using a sensitive scale (0.0000) and calculated relative to their live weight. The carcasses were divided and the thigh, shoulder and breast weight with bone was weighed and calculated relative to carcass weight.
2.5. Statistical Analysis
Data were analyzed using a two-way analysis of variance by SAS [
17], Proc GLM (
p < 0.05), significant differences between means were determined by Duncan multiple range test [
18].
4. Discussion
Tamoxifen exerts mixed antagonistic-agonistic properties, i.e., it shows mammary gland antioestrogenic activity and agonistic effects on the uterus. Nevertheless, it is used to inhibit the adverse effects of oestrogens in endocrine therapy for breast cancer patients [
19].
This experiment was designed to determine the effect on performance and carcass traits of different broiler breeds (Avian48 and Arbor Acres) of oral administration treated with different levels of aromatase inhibitor (Tamoxifen) at an early age. The Avian48 breed attained higher body weight, carcass weight, dressing percentage and percentage carcass cuts compared to the Arbor Acres breed except for thigh percentage and giblets weights that were higher in the Arbor Acres breed. Souza et al. [
20] found that the breast yield of Ross, Cobb and Hubbard was higher than that of Arbor Acres. In addition, Makram et al. [
21] worked on four genetic lines of broiler chicks (Arbor, Avian48, Hubbard and Cobb), recording higher body weight, carcass weight, dressing percentage and percentage edible carcass cuts for the Avian48 breed than the Arbor Acres breed, but thigh percentage and nonedible parts were higher for Arbor Acres than the Avian48 breed.
Oral TAM administration at an early age increased body weight of the two breeds at some weeks but there were no differences at the final weighing. Dewil et al. [
22] concluded similar findings that in-ovo inoculation with fadrazole (another azole-type aromatase inhibitor) enhanced body weight at an early age, but this effect faded by the fifth week of age and their results were due to increased levels of GH, T3 and testosterone resulting from aromatase inhibitor injection. In addition, feed intake increased substantially during the first week of the experiment (second week of age) in Tamoxifen treated groups compared to the control administration than control, with TAM20 groups having numerically higher intake than TAM10 groups, however, the TAM20 and TAM10 supplementation subsequently decreased feed intake compared to the control but this occurred more rapidly in TAM20 treatment. As a result, the total feed conversion ratio for chickens under TAM20 treatment was lower than control and even TAM10. Our findings were in contrast to Nahid et al. [
12] who concluded that there were no significant differences in bird weight, weight gain, feed consumption and feed-to-gain ratio between treated and control groups, but this disparity could be attributable to drug dosage, injection time, number of chickens injected or strain.
With regard to treatment and breed interaction the Arbor Acres breed responded better to Tamoxifen supplementation particularly TAM20 where it increased final body weight, weight gain and reduced feed intake which significantly improved feed conversion ratio than TAM10 and control treatments. However response of the Avian48 breed was better to TAM10 than TAM20 where early supplementation of Avian48 chickens with Tamoxifen 20 mg/kg of body weight decreased its performance compared to control and TAM10. Further work is needed to explain the impact of Tamoxifen on various breeds of broilers.
Supplementation with Tamoxifen did not significantly affect carcass characteristics compared to control procedures; similar findings were concluded in a previous study by Nahid et al. [
12]. While TAM20 increased carcass cuts percentages numerically than TAM10 and control groups in Arbor Acres breed, Avian48 chicken TAM20 given lower carcass characters than TAM10 and control groups. Tamoxifen supplementation did not change the relative percentages of internal organs significantly except for the percentage of the heart, where it was significantly higher than control under TAM10 treatment. Nahid et al. [
12] found that Tamoxifen inoculation in-ovo did not significantly affect internal organs as compared to the control.
Oestrogens, secreted from the ovary in the female, or synthesized by testosterone in situ aromatization in the male, exert a negative feedback effect on the secretion of gonadotropins at the level of both brain and adenohypophysis [
4]. Feeding of juvenile White Leghorn (WL) female chicks on oestrogenic compounds delayed the onset of egg laying by two to three weeks [
23]. On the other hand, antiestrogens can induce gonadotropin secretion and gonadal activity through inhibition of oestrogen binding to its receptors in the brain and pituitary gland [
6].
With regard to the effects of both age and sex on testosterone and oestrogen hormones, our results are in agreement with a previous study [
22], which reported a significant effect of these two factors on levels of such hormones with significantly higher testosterone levels in males compared to females and vice versa for oestrogen. Age, treatment and sex interaction also had a significant effect on testosterone and oestrogen hormones with the highest levels in 42-day male and female birds, respectively, that received Tamoxifen at a dose of 10 mg/kg of body weight compared to those which received 20 mg/kg of body weight. This result is consistent with previous research [
6] which revealed that low doses of TAM improved both oviductal and ovarian development, increased plasma oestrogen and androgen levels with subsequent early egg production in young WL hens. Meanwhile, administration of low doses of TAM to male WL chicks stimulated testicular and comb growth, increased plasma testosterone concentrations with simultaneous precocious semen production and sexual activity. On the other hand, contrary results are produced by high doses of TAM, so it was concluded that TAM has both antiestrogenic and oestrogenic properties in WL male chicks, depending on the dose [
5], and is not a pure oestrogen antagonist as suggested previously. Therefore, it can be concluded that TAM’s antiestrogenic effect stimulates gonadotropic activity, but when the dose was high enough, it competes with the elevated oestrogen in circulation, thereby reducing its efficacy in the target tissues [
6].
The results showed dose-dependent regressive testicular histological alterations. The results reconfirmed the earlier findings which stated the estradiol had an essential role in spermatogenesis [
24]. These observations suggest that reduced oestrogenic action induced by Tamoxifen suppresses spermatogenesis by inhibiting the proliferation and survival of germ cells and by promoting the rate of apoptosis of germ cells. Recent studies on mice treated with Tamoxifen in vivo showed substantial dose-dependent decline in the expression of aromatase enzyme in the testis, which was also associated with sperm decline [
25]. In a human study, Robertson et al. [
26] indicate that Tamoxifen-mediated decreased aromatase synthesis in the testis may cause decreased synthesis of estradiol endogenously which may in effect be responsible for regressed spermatogenesis. In birds, however, it has been known that Tamoxifen has antagonistic properties—it binds to ER receptors and inhibits the effect of oestrogen in the target tissue [
27].
In this study, treatment of broiler chicken with Tamoxifen in different doses caused a gradual decrease in follicle production rate and eventually led to an increase in the atretic follicles at different stages of atresia. This result is consistent with previous findings that have shown that treatment of laying hens with Tamoxifen leads to a reduction in the rate of egg laying and evokes a pause in egg laying [
28]. The gradual decrease in the rate of egg laying after Tamoxifen administration is probably associated with the abolition of the central action of oestrogens at the hypothalamo-pituitary axis. It cannot be ruled out that, by blocking the ER receptors in the central nervous system, Tamoxifen prevents the occurrence of the preovulatory surge of LH in response to progesterone [
29].